BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.

Poussard M, Philippe L, Fredon M, Bôle-Richard E, Biichle S, Renosi F, Perrin S, Kroemer M, Limat S, Bonnefoy F, Daguindau E, Deconinck E, Gruson B, Saas P, Adotévi O, Garnache-Ottou F, Angelot-Delettre F

Open source

DOI
10.1002/jha2.149
Published
2021 Feb
Container
EJHaem
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jha2.149,
  title = {BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.},
  author = {Poussard M and Philippe L and Fredon M and Bôle-Richard E and Biichle S and Renosi F and Perrin S and Kroemer M and Limat S and Bonnefoy F and Daguindau E and Deconinck E and Gruson B and Saas P and Adotévi O and Garnache-Ottou F and Angelot-Delettre F},
  year = {2021},
  journal = {EJHaem},
  doi = {10.1002/jha2.149},
  url = {https://doi.org/10.1002/jha2.149}
}

RIS

TY  - JOUR
TI  - BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.
AU  - Poussard M
AU  - Philippe L
AU  - Fredon M
AU  - Bôle-Richard E
AU  - Biichle S
AU  - Renosi F
AU  - Perrin S
AU  - Kroemer M
AU  - Limat S
AU  - Bonnefoy F
AU  - Daguindau E
AU  - Deconinck E
AU  - Gruson B
AU  - Saas P
AU  - Adotévi O
AU  - Garnache-Ottou F
AU  - Angelot-Delettre F
PY  - 2021
JO  - EJHaem
DO  - 10.1002/jha2.149
UR  - https://doi.org/10.1002/jha2.149
ER  - 

APA

M, P., L, P., M, F., E, B., S, B., F, R., S, P., M, K., S, L., F, B., E, D., E, D., B, G., P, S., O, A., F, G., & F, A. (2021). BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.. EJHaem. https://doi.org/10.1002/jha2.149

Source records